Vaidehi Mahadev Selected Research

6-fluoromevalonolactone

1/2017

MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vaidehi Mahadev Research Topics

Disease

3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2014
3	Neoplasms (Cancer) 01/2020 - 01/2017
3	Glioma (Gliomas) 01/2019 - 01/2014
2	Brain Neoplasms (Brain Tumor) 01/2017 - 01/2014
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Ependymoma 01/2018

Drug/Important Bio-Agent (IBA)

1	mesoglycanIBA 01/2021
1	ChromatinIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	EnzymesIBA 01/2017
1	Mevalonic Acid (Mevalonate)IBA 01/2017
1	NexusIBA 01/2017
1	6-fluoromevalonolactoneIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	Interleukin-13 Receptor alpha2 SubunitIBA 01/2014
1	Chimeric Antigen ReceptorsIBA 01/2014
1	AntibodiesIBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	AntigensIBA 01/2014
1	Cell Surface ReceptorsIBA 01/2014
1	Interleukin-4 (Interleukin 4)IBA 01/2014
1	CytokinesIBA 01/2014
1	Interleukin-13IBA 01/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2014
1	IL13-zetakineIBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
1	Craniotomy 01/2019
1	Radiotherapy 01/2019